Jeremy Sugarman
Johns Hopkins University
413 Papers
2.6K Citations
Jeremy Sugarman is an academic researcher from Johns Hopkins University. The author has contributed to research in topics: Informed consent & Medicine. The author has an hindex of 59, co-authored 393 publications. Previous affiliations of Jeremy Sugarman include Durham University & University of Melbourne.
Chat about Author
Papers
Semantic and Pragmatic Variability in Medical Research Terms: Implications for Obtaining Meaningful Informed Consent
TL;DR: It is a fundamental requirement of scientific research using human subjects that the investigators obtain the informed consent of those subjects, and researchers are therefore generally required to submit informed-consent materials to review boards for approval.
18
Response to open peer commentaries on "Medical and nursing students' television viewing habits: potential implications for bioethics".
TL;DR: The Berman Institute of Bioethics presents a meta-ethics challenge to the accepted view that vaccines and other treatments for infectious disease pose a threat to human dignity and deserve to be investigated.
Enhancing communication among data monitoring committees and institutional review boards.
TL;DR: Overall, a lack of consistency is found in the way that DMC actions are communicated to IRBs, and there is not a clear consensus about either who should be responsible for disseminating the information to the IRB or what information ought to be considered standard.
18
Ethical and policy issues in the clinical translation of stem cells: report of a focus session at the ISSCR Tenth Annual Meeting.
TL;DR: The ethical and regulatory challenges to the clinical translation of stem cell research are described by the Ethics and Public Policy Committee at the ISSCR Tenth Annual Meeting are presented.
18
A Professional Standard for Informed Consent for Stem Cell Therapies.
TL;DR: Over the last decade, there has been an increase in the number of “clinics” offering what is portrayed as “stem cell therapy” for conditions ranging from orthopedic injuries to Alzheimer disease, which suggests that patients who received these interventions were misled.
18